Unleashing Europe’s Biopharmaceutical Innovation Potential: What can be done to accelerate AIDS vaccine research and development?

From:: Department for International Development
Published: 1 January 2008

Document Type:: Briefing
Theme:: Health

Abstract

Europe’s significant scientific capacity could prove pivotal in the quest for an AIDS vaccine. This policy brief discusses key challenges, such as a translational research gap, that must be addressed to best harness Europe’s expertise.

Citation

IAVI Insights: Policy Brief 18. International AIDS Vaccine Initiative (IAVI), New York, NY, USA. 8 pp.